BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26658224)

  • 21. Enzymatic aspects of the phenol (aryl) sulfotransferases.
    Duffel MW; Marshal AD; McPhie P; Sharma V; Jakoby WB
    Drug Metab Rev; 2001; 33(3-4):369-95. PubMed ID: 11768773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carboxyl residues in the active site of human phenol sulfotransferase (SULT1A1).
    Chen G; Rabjohn PA; York JL; Wooldridge C; Zhang D; Falany CN; Radominska-Pandya A
    Biochemistry; 2000 Dec; 39(51):16000-7. PubMed ID: 11123927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The structure of human SULT1A1 crystallized with estradiol. An insight into active site plasticity and substrate inhibition with multi-ring substrates.
    Gamage NU; Tsvetanov S; Duggleby RG; McManus ME; Martin JL
    J Biol Chem; 2005 Dec; 280(50):41482-6. PubMed ID: 16221673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenol sulfotransferase 1A1 activity in human liver: kinetic properties, interindividual variation and re-evaluation of the suitability of 4-nitrophenol as a probe substrate.
    Tabrett CA; Coughtrie MW
    Biochem Pharmacol; 2003 Dec; 66(11):2089-97. PubMed ID: 14609733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variable sulfation of dietary polyphenols by recombinant human sulfotransferase (SULT) 1A1 genetic variants and SULT1E1.
    Ung D; Nagar S
    Drug Metab Dispos; 2007 May; 35(5):740-6. PubMed ID: 17293380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure, dynamics and selectivity in the sulfotransferase family.
    Leyh TS; Cook I; Wang T
    Drug Metab Rev; 2013 Nov; 45(4):423-30. PubMed ID: 24025091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the similar spatial arrangement of active site residues in PAPS-dependent and phenolic sulfate-utilizing sulfotransferases.
    Teramoto T; Adachi R; Sakakibara Y; Liu MC; Suiko M; Kimura M; Kakuta Y
    FEBS Lett; 2009 Sep; 583(18):3091-4. PubMed ID: 19695253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulfotransferase (SULT) 1A1 polymorphic variants *1, *2, and *3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation.
    Nagar S; Walther S; Blanchard RL
    Mol Pharmacol; 2006 Jun; 69(6):2084-92. PubMed ID: 16517757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectrofluorometric assay for monoamine-preferring phenol sulfotransferase (SULT1A3).
    Lu LY; Hsu YC; Yang YS
    Anal Biochem; 2010 Sep; 404(2):241-3. PubMed ID: 20566371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enzyme Kinetics of PAPS-Sulfotransferase.
    James MO
    Methods Mol Biol; 2021; 2342():285-300. PubMed ID: 34272699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a conserved tryptophanyl residue in donor substrate binding and catalysis by a phenol sulfotransferase (SULT1A1).
    Beckmann JD; Chodavarapu S; Doyle B
    Arch Biochem Biophys; 2020 Nov; 695():108621. PubMed ID: 33049293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dimerization is responsible for the structural stability of human sulfotransferase 1A1.
    Lu LY; Chiang HP; Chen WT; Yang YS
    Drug Metab Dispos; 2009 May; 37(5):1083-8. PubMed ID: 19237513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structures of SULT1A2 and SULT1A1 *3: insights into the substrate inhibition and the role of Tyr149 in SULT1A2.
    Lu J; Li H; Zhang J; Li M; Liu MY; An X; Liu MC; Chang W
    Biochem Biophys Res Commun; 2010 May; 396(2):429-34. PubMed ID: 20417180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent inhibition of human sulfotransferase 1A1 by 17α-ethinylestradiol: role of 3'-phosphoadenosine 5'-phosphosulfate binding and structural rearrangements in regulating inhibition and activity.
    Rohn KJ; Cook IT; Leyh TS; Kadlubar SA; Falany CN
    Drug Metab Dispos; 2012 Aug; 40(8):1588-95. PubMed ID: 22593037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human cytosolic sulfotransferase SULT1A1.
    Hempel N; Gamage N; Martin JL; McManus ME
    Int J Biochem Cell Biol; 2007; 39(4):685-9. PubMed ID: 17110154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The NSAID allosteric site of human cytosolic sulfotransferases.
    Wang T; Cook I; Leyh TS
    J Biol Chem; 2017 Dec; 292(49):20305-20312. PubMed ID: 29038294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and localization of cytosolic sulfotransferase (SULT) 1A1 and SULT1A3 in normal human brain.
    Salman ED; Kadlubar SA; Falany CN
    Drug Metab Dispos; 2009 Apr; 37(4):706-9. PubMed ID: 19171676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isotope exchange at equilibrium indicates a steady state ordered kinetic mechanism for human sulfotransferase.
    Tyapochkin E; Cook PF; Chen G
    Biochemistry; 2008 Nov; 47(45):11894-9. PubMed ID: 18928301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP.
    Hsiao YS; Yang YS
    Biochemistry; 2002 Oct; 41(43):12959-66. PubMed ID: 12390022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single amino acid, glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3.
    Dajani R; Hood AM; Coughtrie MW
    Mol Pharmacol; 1998 Dec; 54(6):942-8. PubMed ID: 9855620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.